(1R)-1-(4-chloro-3-fluorophenyl)ethanol | 1016646-05-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (1R)-1-(4-chloro-3-fluorophenyl)ethanol
• 英文别名: (R)-1-(4-Chloro-3-fluorophenyl)ethan-1-ol
• CAS: 1016646-05-1
• 化学式: C₈H₈ClFO
• 分子量: 174.602
• InChiKey: CFEKSJQGYVLAET-RXMQYKEDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (+/-) ethyl [6-fluoro-8-(methylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]acetate 、 (1R)-1-(4-chloro-3-fluorophenyl)ethanol 在 偶氮二甲酸二叔丁酯 、 三苯基膦 作用下， 生成
  参考文献：
  名称：

  Potent and highly selective DP1 antagonists with 2,3,4,9-tetrahydro-1H-carbazole as pharmacophore

  摘要：

  We discovered that the introduction of a methyl group to the benzylic position of the N-benzyl group in lead compound 1a has a dramatic effect on improving the binding selectivity of this ligand for the prostanoid receptors DP1 (receptor for prostaglandin D(2)) as compared to TP (receptor for thromboxane A(2)). Based on this discovery, we have synthesized a series of potent and highly selective DP1 antagonists. Among them, compound 1h was identified as a highly selective DP1 antagonist with excellent overall properties. It has a K(i) of 0.43 nM to DP1 in binding assay and an IC(50) of 2.5 nM in the DP1 functional assay. Its selectivity for DP1 over TP (the most potent receptor after DP1) exceeds 750-fold based on both binding and functional assays. These properties make 1h a very potent and highly selective DP1 receptor antagonist suitable for investigating the biological functions of DP1 in normal physiology and models of disease (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.10.018

文献信息

• Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
  申请人：Beaulieu Christian

  公开号：US20050154044A1

  公开（公告）日：2005-07-14

  The present invention provides substituted tetrahydrocarbazole and cyclopentanoindole derivatives as antagonists of DP receptor, and as such are useful for the treatment of prostaglandin D2 mediated diseases such as rhinitis, asthma and nasal congestion.

  本发明提供了替代四氢咔唑和环戊烷吲哚衍生物作为DP受体拮抗剂，因此可用于治疗前列腺素D2介导的疾病，如鼻炎、哮喘和鼻塞。
• US7019022B2
  申请人：——

  公开号：US7019022B2

  公开（公告）日：2006-03-28
• Potent and highly selective DP1 antagonists with 2,3,4,9-tetrahydro-1H-carbazole as pharmacophore
  作者：Lianhai Li、Christian Beaulieu、Marie-Claude Carriere、Danielle Denis、Gillian Greig、Daniel Guay、Gary O’Neill、Robert Zamboni、Zhaoyin Wang

  DOI：10.1016/j.bmcl.2010.10.018

  日期：2010.12

  We discovered that the introduction of a methyl group to the benzylic position of the N-benzyl group in lead compound 1a has a dramatic effect on improving the binding selectivity of this ligand for the prostanoid receptors DP1 (receptor for prostaglandin D(2)) as compared to TP (receptor for thromboxane A(2)). Based on this discovery, we have synthesized a series of potent and highly selective DP1 antagonists. Among them, compound 1h was identified as a highly selective DP1 antagonist with excellent overall properties. It has a K(i) of 0.43 nM to DP1 in binding assay and an IC(50) of 2.5 nM in the DP1 functional assay. Its selectivity for DP1 over TP (the most potent receptor after DP1) exceeds 750-fold based on both binding and functional assays. These properties make 1h a very potent and highly selective DP1 receptor antagonist suitable for investigating the biological functions of DP1 in normal physiology and models of disease (C) 2010 Elsevier Ltd. All rights reserved.